Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$31.97 - $49.37 $742,727 - $1.15 Million
23,232 Added 54.63%
65,761 $2.14 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $318,567 - $681,953
-8,946 Reduced 17.38%
42,529 $1.68 Million
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $433,484 - $621,608
7,531 Added 17.14%
51,475 $3.6 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $263,591 - $362,350
2,921 Added 7.12%
43,944 $4.2 Million
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $2.95 Million - $3.92 Million
25,311 Added 161.09%
41,023 $5.41 Million
Q3 2020

Oct 30, 2020

BUY
$72.92 - $102.01 $59,721 - $83,546
819 Added 5.5%
15,712 $1.6 Million
Q2 2020

Aug 11, 2020

BUY
$55.75 - $92.75 $830,284 - $1.38 Million
14,893 New
14,893 $1.29 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.